Inactive Instrument
Epigenomics AG Stock Xetra
Stocks
DE000A1K0516
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
Other stock markets
|
||
| - EUR | - |
|
| 04-02 | Epigenomics AG Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 25-07-22 | Epigenomics AG Reports Earnings Results for the Half Year Ended June 30, 2025 | CI |
| Market Cap | 824K 943K 761K 701K 1.32M 90.84M 1.35M 9.09M 3.58M 44.49M 3.54M 3.46M 153M | P/E 2024 |
-0.29x | P/E 2025 | -2.51x |
|---|---|---|---|---|---|
| Enterprise Value | 11.79M 13.49M 10.88M 10.03M 18.9M 1.3B 19.32M 130M 51.15M 636M 50.67M 49.56M 2.19B | EV / Sales 2024 |
-
| EV / Sales 2025 | 490x |
| Free-Float |
70.75% | Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Frederic Hilke
IRC | Investor Relations Contact | - | - |
| Corporate Officer/Principal | 55 | 2024-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Helge Lubenow
CHM | Chairman | 58 | 2023-02-28 |
Alexander Link
BRD | Director/Board Member | 55 | 2020-05-31 |
Jochen Hummel
BRD | Director/Board Member | 56 | 2024-02-04 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.15% | +3.79% | +144.14% | +97.63% | 4.72B | |
| +3.71% | +8.83% | +118.29% | +210.99% | 3.67B | |
| -5.50% | -0.75% | -29.85% | -37.41% | 2.04B | |
| -1.51% | +39.35% | +236.41% | +292.59% | 2.05B | |
| +7.30% | +18.20% | +113.68% | -37.66% | 2.23B | |
| +2.12% | +18.88% | +188.45% | -42.17% | 1.07B | |
| -2.39% | -1.55% | -12.29% | +35.95% | 875M | |
| -4.16% | +6.17% | -33.94% | -12.03% | 513M | |
| -3.06% | -3.18% | -2.02% | - | 476M | |
| Average | -0.40% | +10.13% | +80.32% | +63.49% | 1.96B | |
| Weighted average by Cap. | +0.65% | +10.76% | +111.37% | +96.44% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 24K 27.46K 22.15K 20.41K 38.48K 2.64M 39.33K 265K 104K 1.3M 103K 101K 4.46M |
| Net income | -3.35M -3.84M -3.09M -2.85M -5.37M -369M -5.49M -36.97M -14.54M -181M -14.4M -14.09M -623M | -314K -359K -290K -267K -503K -34.6M -515K -3.46M -1.36M -16.95M -1.35M -1.32M -58.34M |
| Net Debt | 10.46M 11.96M 9.65M 8.89M 16.76M 1.15B 17.13M 115M 45.36M 564M 44.93M 43.94M 1.94B | 10.97M 12.55M 10.12M 9.33M 17.58M 1.21B 17.97M 121M 47.58M 592M 47.13M 46.1M 2.04B |
Employees
-
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
